AlphaGrep UK Ltd’s Medtronic MDT Stock Holding History

AlphaGrep UK Ltd’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,765	Closed	-$266K	–	875
2025 Q4	$266K	Buy	+2,765	New	+$269K	0.09%	498

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AlphaGrep UK Ltd's MDT Position: Q1 2026 in Review

AlphaGrep UK Ltd sold out of Medtronic (MDT) in Q1 2026, closing a stake of 2,765 shares — an estimated $266K sold.

AlphaGrep UK Ltd first reported a position in MDT in Q4 2025 and held it in 1 quarter. The position peaked at $266K in Q4 2025. 2,241 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

AlphaGrep UK Ltd reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
AlphaGrep UK Ltd sold 2,765 Medtronic shares in Q1 2026, an estimated $266K.
AlphaGrep UK Ltd first reported a position in Medtronic in Q4 2025 and held it in 1 quarter.
AlphaGrep UK Ltd's Medtronic position peaked at $266K in Q4 2025.
2,241 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.